Product Name:Human Glutamate receptor- interacting protein 1, GRIP1 ELISA KITPacking:96T
Catalog No.:ELI-08298h
Gene Name:GRIP1
Detect Range:0.312-20 ng/mL
Sensitivity:0.039ng/mL
Target Protein Name:Glutamate receptor-interacting protein 1(GRIP1
Alternative Name:GRIP1,Glutamate receptor-interacting protein 1(GRIP1Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA KitProduct Description:Human Glutamate receptor- interacting protein 1, GRIP1 ELISA KIT allows for the in vitro quantitative determination of Glutamate receptor-interacting protein 1(GRIP1 concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:The microtiter plate provided in Human Glutamate receptor- interacting protein 1, GRIP1 ELISA KIT has been pre-coated with an Glutamate receptor-interacting protein 1(GRIP1 antibody specific to Glutamate receptor-interacting protein 1(GRIP1 .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Glutamate receptor-interacting protein 1(GRIP1 and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Glutamate receptor-interacting protein 1(GRIP1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of Glutamate receptor-interacting protein 1(GRIP1 in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway: Double Antibody Sandwich Method (双抗体夹心法). This ensures maximum reproducibility across clinical research and scientific workflows.